Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Sara Costa-Cabral

A Novel Tankyrase Inhibitor, MSC2504877, Enhances the Effects of Clinical CDK4/6 Inhibitors

Scientific Reports

Multidisciplinary

English

Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours

Multidisciplinary

English

Related publications

Chemoproteomics Reveals Novel Protein and Lipid Kinase Targets of Clinical CDK4/6 Inhibitors in Lung Cancer

ACS Chemical Biology

Molecular Medicine

English

Preclinical Characterization of G1T28: A Novel CDK4/6 Inhibitor for Reduction of Chemotherapy-Induced Myelosuppression

Molecular Cancer Therapeutics

Cancer Research

English

Cdk4/6-Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 Status

Clinical Cancer Research

Cancer Research

English

The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade

Molecular Biology

English

Treating ER+ Breast Cancer With CDK4/6 Inhibitors

Cancer Discovery

English

CDK4/6 Inhibitors: Promising Opportunities Beyond Breast Cancer

Cancer Discovery

English

A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma

Clinical Cancer Research

Cancer Research

English

Palbociclib: First CDK4/6 Inhibitor in Clinical Practice for the Treatment of Advanced HR-Positive Breast Cancer

English

CDK4/6 Inhibitors resTORe Therapeutic Sensitivity in HER2 + Breast Cancer

Cancer Research

English